In recent years, studies using [11C]harmine, [11C]DASB, and [18F]FDG PET proved that light therapy can modulate the levels of MAO-A, 5-HTT, and glucose metabolism in the brain of depression patients6,7,48. Here, SLC6A4 is linked to depressive symptom measurement.